For pharmaceutical and biotech companies

Rigorous evidence work, delivered by clinicians.

A clinician-led team delivering evidence synthesis, medical writing, and real-world data analysis for medical affairs, HEOR, and safety teams. Every deliverable is produced and verified by named physicians and biostatisticians who stand behind it.

Request a proposal For hospitals and universities

Service lines

Every engagement is scoped and quoted individually. No public pricing.

Evidence synthesis and systematic reviews

Protocol development, systematic screening with dual reviewer agreement, data extraction, and PRISMA 2020 compliant reporting for literature reviews, SLRs, and meta-analyses.

Medical writing and publications

Manuscripts, congress abstracts, posters, and plain-language summaries prepared in line with ICMJE authorship criteria and Good Publication Practice (GPP 2022). Writing support is always disclosed; we never ghost-author.

Real-world evidence and biostatistics

Study design, statistical analysis plans, and analysis of registries, claims, and observational datasets, led by senior academic biostatistics expertise.

Safety literature screening support

Systematic triage of published literature for adverse event mentions with documented reviewer sign-off, delivered as screening outputs ready for your pharmacovigilance workflow.

Medical education and scientific communication

Slide decks, training modules, advisory board pre-reads, and summaries that are referenced, accurate, and ready for medical review.

Research strategy and methodology consulting

Study design guidance, evidence gap assessment, and publication planning for medical affairs and HEOR teams, grounded in current reporting standards.

How we work

The rigor comes from method. The trust comes from who signs off.

Clinician-led at every step

Named physicians and biostatisticians design, produce, and approve the work, and stand behind every deliverable.

Rigorous by standard

Every citation is checked against its source, and every clinical statement is reviewed before delivery. Methods follow PRISMA, GPP 2022, and ICMJE.

Confidential by default

We work on de-identified data under signed agreements, and your materials are never shared or reused.

The lines we do not cross

Authorship and contributorship follow the ICMJE criteria and GPP 2022; professional writing support is disclosed, never hidden.
No guaranteed journal acceptance, no fabricated or embellished data, no selective reporting on request.
Every deliverable is reviewed and signed off by a named physician or biostatistician before it reaches you.
Identified patient data never touches our systems; engagements run on de-identified data under signed agreements.

Request a proposal

Tell us what you need; we reply within two business days with a scoped approach.

Engagements are delivered by Health Research Accelerator (Canada). Work runs on de-identified data under signed agreements.